These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26548013)

  • 1. [Biomarkers for the diagnosis of fatigue in patients with multiple sclerosis].
    Rosche B
    Versicherungsmedizin; 2015 Sep; 67(3):148-51. PubMed ID: 26548013
    [No Abstract]   [Full Text] [Related]  

  • 2. [The appraisal of fatigue in multiple sclerosis].
    Hausotter W
    Versicherungsmedizin; 2009 Mar; 61(1):15-8. PubMed ID: 19370840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
    Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
    Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatigue in multiple sclerosis: a diagnostic and therapeutic challenge.
    Paul F; Veauthier C
    Expert Opin Pharmacother; 2012 Apr; 13(6):791-3. PubMed ID: 22424379
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis.
    Pfuhl C; Oechtering J; Rasche L; Gieß RM; Behrens JR; Wakonig K; Freitag E; Pache FC; Otto C; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
    J Neuroimmunol; 2015 Aug; 285():156-60. PubMed ID: 26198934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue at time of CIS is an independent predictor of a subsequent diagnosis of multiple sclerosis.
    Runia TF; Jafari N; Siepman DA; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):543-6. PubMed ID: 25053770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining reliable change on the modified fatigue impact scale (5-item version).
    Smith J; Bruce AS; Glusman M; Thelen J; Lynch S; Bruce JM
    Mult Scler Relat Disord; 2018 Feb; 20():22-24. PubMed ID: 29275058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fatigue in patients with multiple sclerosis--pathogenesis, clinical picture, diagnosis and treatment].
    Patejdl R; Penner IK; Noack TK; Zettl UK
    Fortschr Neurol Psychiatr; 2015 Apr; 83(4):211-20. PubMed ID: 25893494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging by voxel-based morphometry: possible approach to finding the correlation between brain structural changes and fatigue severity in patients with multiple sclerosis.
    Chen Q
    AJNR Am J Neuroradiol; 2011 May; 32(5):880-1. PubMed ID: 21474627
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
    Ruprecht K; Wunderlich B; Gieß R; Meyer P; Loebel M; Lenz K; Hofmann J; Rosche B; Wengert O; Paul F; Reimer U; Scheibenbogen C
    J Neuroimmunol; 2014 Jul; 272(1-2):56-61. PubMed ID: 24798244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
    J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBNA1 antigen-specific CD8+ T cells in cerebrospinal fluid of patients with multiple sclerosis.
    Erdur H; Scholz V; Streitz M; Hammer M; Meisel C; Schönemann C; Wandinger KP; Rosche B
    J Neuroimmunol; 2016 May; 294():14-7. PubMed ID: 27138093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid screening tool for fatigue impact in multiple sclerosis.
    Kos D; Nagels G; D'Hooghe MB; Duportail M; Kerckhofs E
    BMC Neurol; 2006 Aug; 6():27. PubMed ID: 16916440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of fatigue and contributing neuropsychiatric factors.
    Elkins LE; Krupp LB; Scherl W
    Semin Clin Neuropsychiatry; 2000 Jan; 5(1):58-61. PubMed ID: 10704539
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fatigue scales used in multiple sclerosis].
    Debouverie M; Pittion S; Guillemin F; Vespignani H
    Rev Neurol (Paris); 2002 Nov; 158(11):1139-43. PubMed ID: 12451351
    [No Abstract]   [Full Text] [Related]  

  • 16. The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins.
    Dooley MM; de Gannes SL; Fu KA; Lindsey JW
    J Neuroimmunol; 2016 Oct; 299():147-151. PubMed ID: 27725113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cognition and fatigue in multiple sclerosis: daily practice and future directions.
    Penner IK
    Acta Neurol Scand; 2016 Sep; 134 Suppl 200():19-23. PubMed ID: 27580902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proposal of a new scale for assessing fatigue in patients with multiple sclerosis].
    Iriarte J; de Castro P
    Neurologia; 1994 Mar; 9(3):96-100. PubMed ID: 8204266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue in multiple sclerosis: an overview of assessment and pharmacologic treatment.
    Dunmore FR
    Adv NPs PAs; 2013 Apr; 4(4):23-5, 32. PubMed ID: 23599993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Workshop on fatigue and multiple sclerosis].
    Montreuil M; Vernay D
    Rev Neurol (Paris); 2000 Nov; 156(11):1057-8. PubMed ID: 11119067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.